RxSight
RXST
174 hedge funds and large institutions have $481M invested in RxSight in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 39 reducing their positions, and 50 closing their positions.
90% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 39
0.78% more ownership
Funds ownership: 90.32% → 91.09% (+0.78%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 192 → 174 (-18)
28% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 50
48% less capital invested
Capital invested by funds: $923M → $481M (-$442M)
88% less call options, than puts
Call options by funds: $455K | Put options by funds: $3.83M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$19.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.9M |
| 4 |
NSGL
No Street GP LP
San Francisco,
California
|
+$9.02M |
| 5 |
Morgan Stanley
New York
|
+$8.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$30.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.2M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$10.8M |
| 4 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$10.6M |
| 5 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$10M |
RXST Hedge Fund Activity: Q2 2025 in Review
174 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q2 2025, worth a combined $481M — down 48% from $923M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of RXST and 36 opened new positions — a net loss of 14 holders — while 39 trimmed existing stakes and 74 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $19.5M. The largest seller was Bank of America, cutting an estimated $30.7M.
- 174 institutional investors held RxSight (RXST) as of Q2 2025, down from 192 in Q1 2025.
- Funds reported $481M of RxSight stock for Q2 2025, down 48% quarter-over-quarter.
- 36 funds opened new RxSight positions in Q2 2025 and 50 closed out, a net change of -14 holders.
- The largest RxSight buyer in Q2 2025 was D.E. Shaw & Co, an estimated $19.5M added.
- The largest RxSight seller in Q2 2025 was Bank of America, an estimated $30.7M sold.
Based on aggregated 13F filings for Q2 2025.